News
PRE
18.80
+2.96%
0.54
Weekly Report: what happened at PRE last week (0803-0807)?
Weekly Report · 1d ago
Prenetics Secures $1 Billion General Catalyst Growth Financing for IM8 Business
TipRanks · 3d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 08/04 12:05
Weekly Report: what happened at PRE last week (0727-0731)?
Weekly Report · 08/03 10:11
Press Release: First Horizon Declares Cash Dividends on Common and Preferred Stock
Dow Jones · 07/28 20:35
Weekly Report: what happened at PRE last week (0720-0724)?
Weekly Report · 07/27 10:15
Prenetics Global: Path To Profitability On Course With Financing Deal
Seeking Alpha · 07/23 12:15
Weekly Report: what happened at PRE last week (0713-0717)?
Weekly Report · 07/20 10:11
Roth MKM Reaffirms Their Buy Rating on Prenetics Group (PRE)
TipRanks · 07/15 20:37
Prenetics Global Price Target Raised to $40.00/Share From $30.00 by Benchmark
Dow Jones · 07/15 14:54
Prenetics Global Is Maintained at Buy by Benchmark
Dow Jones · 07/15 14:54
Benchmark Maintains Buy on Prenetics Global, Raises Price Target to $40
Benzinga · 07/15 14:44
Prenetics price target raised to $35 from $29 at Lake Street
TipRanks · 07/15 12:15
Prenetics price target raised to $40 from $30 at Benchmark
TipRanks · 07/15 11:50
Prenetics’ IM8 Secures $1 Billion Non-Dilutive Financing as Revenue Outlook Rises
TipRanks · 07/14 20:29
Prenetics Global Announces Closing Of $1B In Growth Financing From General Catalyst’s Customer Value Fund; Co. Raises FY26 IM8 Revenue Guidance To $210M-$220M, Up From $190M-$210M
Benzinga · 07/14 18:01
Prenetics ups IM8 sales outlook amid growth financing, Bloomberg says
TipRanks · 07/14 17:15
Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)
Barchart · 07/14 12:35
Weekly Report: what happened at PRE last week (0706-0710)?
Weekly Report · 07/13 10:13
Weekly Report: what happened at PRE last week (0629-0703)?
Weekly Report · 07/06 10:17
More
Webull provides a variety of real-time PRE stock news. You can receive the latest news about Prenetics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PRE
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.